New Pill For MS Tested

“A new oral drug for multiple sclerosis has produced promising results in clinical trials,” BBC News reported. It said the new drug, laquinimod, improved the condition of patients with the relapse-remitting form of multiple sclerosis (MS) with few side-effects. Scans showed that patients taking a high dose of the drug had 40% less damage than those taking a placebo. The BBC explained that an oral drug could be a significant advance as existing MS drugs all need to be injected.

More: continued here

Filed under: Multiple Sclerosis on June 30th, 2008